statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	762
DE - Germania	185
CN - Cina	165
SG - Singapore	158
SE - Svezia	118
PL - Polonia	100
BR - Brasile	78
IT - Italia	60
GB - Regno Unito	33
UA - Ucraina	33
FR - Francia	27
IE - Irlanda	24
VN - Vietnam	16
BE - Belgio	15
FI - Finlandia	15
IN - India	15
ID - Indonesia	14
TR - Turchia	12
CA - Canada	10
RU - Federazione Russa	8
HK - Hong Kong	7
MX - Messico	6
IL - Israele	5
JP - Giappone	5
BD - Bangladesh	4
ES - Italia	4
IR - Iran	4
JO - Giordania	4
KR - Corea	4
LT - Lituania	4
PT - Portogallo	4
SA - Arabia Saudita	4
ZA - Sudafrica	4
AR - Argentina	3
CO - Colombia	3
NL - Olanda	3
AE - Emirati Arabi Uniti	2
AU - Australia	2
CH - Svizzera	2
CL - Cile	2
IM - Isola di Man	2
IQ - Iraq	2
PA - Panama	2
PK - Pakistan	2
RO - Romania	2
TW - Taiwan	2
UZ - Uzbekistan	2
AL - Albania	1
AO - Angola	1
AT - Austria	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BO - Bolivia	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EC - Ecuador	1
EE - Estonia	1
GE - Georgia	1
GF - Guiana Francese	1
KE - Kenya	1
KZ - Kazakistan	1
LV - Lettonia	1
MK - Macedonia	1
MY - Malesia	1
NO - Norvegia	1
PE - Perù	1
SK - Slovacchia (Repubblica Slovacca)	1
SO - Somalia	1
TJ - Tagikistan	1
TN - Tunisia	1
UG - Uganda	1
VE - Venezuela	1
Totale	1.964

Nome	#
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD	304
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	210
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease	165
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease	162
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease	155
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases	153
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD	149
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease	143
Investigational prostaglandin D2 receptor antagonists for airway inflammation	141
Dupilumab for the treatment of asthma	134
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	107
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	87
Metabolomic analysis by nuclear magnetic resonance spectroscopy as a new approach to understanding inflammation and monitoring of pharmacological therapy in children and young adults with cystic fibrosis	73
Totale	1.983

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	95	0	0	0	0	0	5	9	8	36	16	19	2
2021/2022	147	7	15	2	25	8	3	4	20	6	11	22	24
2022/2023	338	44	52	20	60	32	34	12	25	47	2	6	4
2023/2024	135	9	40	3	14	8	23	13	1	0	4	11	9
2024/2025	249	6	10	17	16	33	11	14	4	29	18	52	39
2025/2026	334	102	24	26	47	116	19	0	0	0	0	0	0
Totale													1.983

IRIS UniCatt